The chromatin regulator HDAC7 controls the development and effector function of iNKT 16 cells via direct interaction with their signature transcription factor PLZF, a finding that provides a mechanism 17 explaining the strong statistical association between HDAC7 variants and the autoimmune diseases IBD and 18 PSC.
Introduction 1
To become mature T cells, thymocytes must navigate through a complex process of selection and 2 instruction, centered around signals received through their newly created T cell antigen receptors (TCRs) . 3 For thymocytes destined to become conventional naïve CD4 or CD8 T cells (Tconv), this requires passing in a gastrointestinal/hepatobiliary compartment that is anatomically tied together by the contiguous epithelial 1 surfaces of the GI lumen and the pancreatic and biliary ductal systems (Kasler et al. 2012) . 2 The potential significance of this peculiar pattern of HDAC7-mediated autoimmunity for human 3 disease has recently been brought into sharp focus by two separate studies identifying polymorphisms at the 4 loci of HDAC7 as well as several of its upstream regulatory kinases as independent risk factors in human 5 inflammatory bowel disease (IBD), and also in primary sclerosing cholangitis (PSC), a destructive 6 autoimmune syndrome of the hepatobiliary system, which is additionally associated with increased IBD risk 7 (Liu et al. 2013 , Jostins et al. 2012 . The striking parallel between these human syndromes and the 8 autoimmunity observed in HDAC7ΔP transgenic mice suggested to us a connection between HDAC7 and 9 these types of autoimmunity that goes beyond simply blocking thymic negative selection. This led us to 10 undertake a more thorough phenotypic characterization of mice with altered HDAC7 function during T cell 11 development, revealing that HDAC7 has a key role in the regulation of the innate effector programming of 12 iNKT cells, at least in part via direct modulation of the transcriptional activity of PLZF. Both gain and loss of 13 HDAC7 function in thymocytes resulted in aberrant effector programming of T cells in both the Tconv and 14 innate-like lineages, leading to multiple abnormalities in peripheral populations. These studies shed new light 15 on the molecular pathways that regulate the effector programming of innate-like T cells, reveal a new key 16 molecular target of HDAC7 in T cell development, and set forth a novel cellular model of autoimmunity in 17 which one genetic lesion mediates multiple defects in thymic selection, which converge in the periphery to 18 produce a unique, tissue-restricted pattern of disease. Given the established genetic association between 19 HDAC7 and very similar human syndromes, our findings are likely to be of considerable significance in the 20 understanding of these diseases. 21 
Results

23
Alteration of HDAC7 Function Dysregulates Thymic Innate Effector Programming and Interferes With iNKT
24 Development 1 at normal levels during thymic T cell development but not in mature T cells, autoreactive cells that would 2 normally die by negative selection instead exit the thymus as naïve Tconv (Kasler et al. 2012) . However in 3 our previous study we did not assess the fates of cells destined to become innate effectors. Analyzing these 4 populations, we noted a modest suppression of Treg and CD8αα IEL (not shown), but the most striking 5 observation we made was the near total absence of invariant Natural Killer T cells (iNKT), an oligoclonal 6 population that is reactive to α-galactosylceramide (αGalCer) presented by the CD1D non-canonical MHC 7 molecule (CD1D/αGalCer) (Kronenberg 2014) . Cells positive for staining with CD1D/αGalCer tetramers 8 represent approximately 3% of TCRβ-positive cells in wild type C57BL/6 (B6) thymus and 30% in liver, 9 however they are nearly undetectable in either of these tissues or in the spleens of HDAC7ΔP mice (Fig. 1A,   10 B, Fig. S1A, B ), suggesting a profound, early block in iNKT development. The few tetramer-binding cells 11 remaining in HDAC7ΔP mice were CD24lo, but failed to upregulate either CD44 or NK1.1 (Fig. 1C ), 12 indicating a Stage 1 block according to the conventional staging system for iNKT development (Stritesky, 13 Jameson, and Hogquist 2012). We also evaluated the prevalence of CD44/NK1.1-expressing T cells that were 14 not tetramer-reactive, and noted a marked reduction in their numbers as well ( Fig. S1E-F) , indicating a broad 15 defect in the development of the NKT lineage. 16 To rule out cell-extrinsic mechanisms for this block, we generated mixed hematopoietic chimeras 17 reconstituted with a 1:1 mixture of wild-type (WT) and HDAC7ΔP bone marrow. As we previously reported 18 (Kasler et al. 2012) , the HDAC7ΔP transgenic population contributed robustly to the pool of CD4 and CD8 19 SP thymocytes, although there was a transient reduction in prevalence at the immature single positive (ISP) 20 stage ( Fig. S1C ). At early time points post-reconstitution (6-8wk), the distributions of naïve and memory T-21 cells in peripheral CD4+ and CD8+ Tconv subsets were equivalent as well ( Fig S1D) . However, while the 22 wild type-derived population reconstituted hepatic iNKT cells efficiently, HDAC7ΔP bone marrow failed to 23 contribute significantly to this compartment (Fig. 1D, E) . This was also true in the thymus and spleen (Fig. 24 1E), demonstrating that the block observed in the intact transgenic mice was due to a cell-autonomous 25 mechanism.
We next examined the effects of loss of HDAC7 in the thymus on these phenotypes, using our 1 previously characterized strain that deletes loxp-flanked HDAC7 under the control of the p56lck proximal 2 promoter (HDAC7 flox/lck-cre, henceforth HDAC7 KO) (Kasler et al. 2011) . We previously reported that 3 loss of HDAC7 during T cell development increased apoptosis of DP thymocytes leading to inefficient 4 positive selection. This shortened thymocyte lifespan resulted in a truncation of the TCR Jα repertoire, with 5 distal rearrangements underrepresented (Kasler et al. 2011) . It was thus not surprising to find that HDAC7 6 KO mice with an endogenous TCR repertoire had fewer iNKT cells than WT controls; for example, HDAC7 7 KO liver contained 80-90% fewer iNKT cells as a proportion of TCRβ+ T-cells (Fig. 3A) . This roughly five-8 fold reduction, consistent with the degree of underrepresentation of the relatively distal Jα18 TCR segment 9 we previously noted (Kasler et al. 2011) , was similarly observed in the spleen and thymus ( Fig. S3B ). 10 Importantly, unlike the residual tetramer-reactive cells in HDAC7ΔP mice, iNKT calls in HDAC7 KO mice 11 had normal expression of CD44 and NK1.1, suggesting that their development was not functionally altered. 12 (Fig, 2B ) 13 Although deletion of HDAC7 did not result in expansion of NK1.1-expressing T cells, we did observe 14 significant abnormalities in the effector programming of non-tetramer-reactive thymocytes. We noted a 15 substantial expansion of a CD44hi Eomes+ population in the mature CD8 SP compartment in the thymus (Fig. 16 2C-D). Examination of the peripheral CD8 T cells in these animals also showed a substantial increase in CD44 17 expression, suggesting an expansion of innate effector CD8 cells ( Fig. 2E ). These cells resemble Eomes+ 18 innate memory CD8+ cells that are typically generated in trans, in response to IL4 secretion by thymic-19 resident iNKT cells (Lee et al. 2013 , Weinreich et al. 2010 , however as previously noted iNKTcells are 20 depleted rather than expanded in HDAC7 KO mice, suggesting a different mechanism. To clarify this 21 question, we examined the phenotypes resulting from loss of HDAC7 in WT: HDAC7 KO mixed 22 hematopoietic chimeras. 23 In 1:1 chimeras, HDAC7 KO thymocytes competed equally through the ISP stage, but thereafter 24 competed poorly and became steadily less abundant. This substantial underrepresentation of HDAC7 KO 1 however their representation in the periphery was sufficient. In the spleen, we saw a strong increase in CD44 2 expression in the HDAC7 KO-derived vs. to the WT-derived CD8 T cell population ( Fig. 2F-G) , duplicating 3 what we saw in the intact mice and indicating that the phenotypes we observed are likely cell-autonomous. 4 To further characterize the phenotype of these cells, we briefly stimulated splenocytes from these chimeras 5 ex vivo, and found that HDAC7 KO-derived CD8+ T-cells produced much more IFNγ than WT-derived CD8+ 6 T-cells in the same culture, assessed both as percent cytokine-positive ( Fig. 3H , I) and by median fluorescence 7 intensity (MFI) of cytokine staining (Fig. 3J ). CD8+ T-cells from HDAC7 KO population also had increased 8 expression of the Eomes-associated chemokine receptor CXCR3 and the trafficking receptor Ly6C (Fig. S2C ).
9
Loss of HDAC7 thus appears to result in the aberrant adoption of NKT-like innate effector 10 programming by CD8 SP thymocytes that would otherwise have exited the thymus as naive Tconv. We 11 observed a much more modest degree of abnormality in the CD4 compartment (not shown), which we 12 hypothesize is due to the greater similarity that CD8 thymic selection bears to NKT selection, in terms of both 13 the similarity of CD1D to Class I MHC and the availability of selecting ligands on all thymocytes rather than 14 just on specialized thymic APC. Loss of HDAC7 may thus allow some DP thymocytes to aberrantly adopt 15 this lineage through some partial analogue of NKT selection. Collectively, our findings with both the HDAC7 16 knockout and HDAC7ΔP transgene findings suggest that HDAC7 may function as a gatekeeper of innate 17 effector programming, blocking the functional maturation of iNKT cells when constitutively expressed in the 18 nucleus, and conversely allowing the aberrant acquisition of innate effector characteristics in CD8 T cells 19 when it is conditionally deleted. 20 21
HDAC7 Regulates the Effector Programming of NKT Cells in a Manner That Mirrors the Function of PLZF
22
To generate a larger population of iNKT precursors for more in-depth evaluation the role of HDAC7, 23 we employed the Vα14-Jα18 TCRα transgene (henceforth "Vα14"), encoding the invariant TCR α chain that 24 when paired with the appropriate endogenous β chains allows iNKT cells to bind glycolipids with high affinity (Griewank et al. 2007) . Expressing this TCR transgene greatly increases the frequency of CD1D/αGalCer-1 reactive thymocytes, which arise naturally only at only around 1 in 10 4 cells. As expected, mice expressing 2 only the Vα14 transgene had many more iNKT cells in thymus and spleen than WT mice (Figs. 3A-B and 3 S3A-B). Also consistent with our expectations, when we crossed the Vα14 TCRα transgene into the HDAC7 4 KO strain, we observed a complete rescue of iNKT cell abundance in the thymus and periphery ( Fig. S3A -5 B), resulting in identical numbers between Vα14 and Vα14 HDAC7 KO mice. These cells were 6 phenotypically similar to WT iNKT cells in terms of CD44/NK1.1 expression and cytokine production (not 7 shown), suggesting that shortened thymocyte lifespan was indeed the key cause of the lowered iNKT 8 abundance in HDAC7 KO mice. 9 In contrast to this finding, when the Vα14 transgene was co-expressed with HDAC7ΔP, the rescue in 10 the numbers of CD1D/αGalCer-reactive cells was incomplete ( Fig. 3A-B ), and the cells were phenotypically 11 abnormal ( Fig. 3, S3 ). This result suggests that rather than blocking the maturation of CD1D/αGalCer-reactive 12 cells categorically, HDAC7ΔP blocked the intrathymic proliferation that is normally associated with post-13 positive selection iNKT differentiation (Benlagha et al. 2002) , directing the cells instead to mature without 14 proliferating, as if they were positively selected Tconv. Consistent with this idea, other characteristics of 15 CD1D/αGalCer-reactive Vα14 x HDAC7ΔP T cells were similar to those of naïve Tconv. Flow analysis 16 revealed that like the residual tetramer-reactive cells present in the HDAC7ΔP mice (Fig. 1C ) the rescued 17 iNKT cells in Vα14 x HDAC7ΔP mice failed to upregulate the memory marker CD44 or the NKT marker 18 NK1.1 in the thymus like their Vα14-only counterparts (Fig. 3C , top row). This phenotype persisted in the 19 spleen, after the HDAC7ΔP transgene was turned off (Fig. 2C , bottom row), suggesting that the cells had 20 failed to undergo effector programming in the thymus. 21 We next examined their cytokine responses to brief ex-vivo stimulation. When stimulated for 4 hours 22 with PMA/ionomycin, CD1D/αGalCer-reactive WT and Vα14 transgenic iNKT cells exhibited a robust 23 cytokine response, secreting both IFNγ and IL-4. In contrast, Vα14 x HDAC7ΔP iNKT were far less likely to 24 make IFNγ or IL-4 ( Fig. 3D-E ), as would be expected for naïve Tconv. Additionally, iNKT cells typically express high levels of the integrin LFA-1 (CD11a/CD18), allowing them to remain localized in tissue-specific 1 vascular beds such as hepatic sinusoids (Thomas et al. 2011) . In contrast, Vα14 x HDAC7ΔP iNKT cells 2 exhibited far lower expression levels ( Fig. 3F -G), comparable to those seen in circulating non-3 CD1D/αGalCer-reactive CD4+ (mainly naïve) T-cells ( Fig. 3G, right) . Moreover, while Vα14 x HDAC7ΔP 4 iNKT cells were found at comparable frequency in spleen to WT iNKT cells, they failed to concentrate in 5 peripheral tissues such as the liver (Fig. S3C-D) , a behavior more characteristic of naïve Tconv rather than 6 iNKT cells. Thus, constitutively nuclear HDAC7, encoded by HDAC7ΔP, prevents iNKT precursors from 7 initiating innate effector development. As they have low CD44 expression, produce few cytokines after brief 8 stimulation, and freely recirculate, they appear to become diverted into functionally naïve-like T-cells. CD44hiNK1.1+ profile ( Fig. S1E-F ). HDAC7 and PLZF thus appear to play nearly inverse roles in iNKT 20 development ( Fig. 4E ). 21 One possible mechanism for this inverse relationship is the idea that nuclear HDAC7 represses the 22 expression of PLZF, preventing HDAC7ΔP thymocytes from expressing PLZF (Seiler et al. 2012 ). Indeed, 23 we observed a pronounced reduction in PLZF expression in TCRβ+ T-cells from HDAC7ΔP mice in all 24 organs examined, including thymus, spleen and liver ( Fig. 4A, B ). However, robust PLZF was still detected in CD4+ SP thymocytes from Vα14 x HDAC7ΔP mice; although expression was restricted compared to 1 Vα14-only thymus ( Fig. 4C ), Interestingly, PLZF expression was maintained in roughly half of splenic Vα14 2 x HDAC7ΔP iNKT cells ( Fig. 4D , right panel). Thus, transcriptional repression of PLZF expression by 3 HDAC7 is probably insufficient to fully explain the iNKT block, as even PLZF+ Vα14 x HDAC7ΔP iNKT 4 cells remain naïve-like, Stage 1-arrested T-cells ( Fig. 3C ). down) that were suppressed by HDAC7ΔP ( Fig. 5A , green plot points and numbers) greatly outnumbered 23 those enhanced by HDAC7ΔP ( Fig. 5A , red plot points and numbers) in both spleen and thymus. Strongly 24 induced genes involved in iNKT cell development that were suppressed by HDAC7ΔP included ID2, PLZF, NK1.1, T-bet, Gata3, IL4, IFNG, and Hobit, a zinc-finger transcription factor recently shown to be essential 1 for the acquisition of tissue-resident effector function (Mackay et al. 2016) ( Fig. 5A , labeled points). This 2 pattern of suppression was established in the thymus (Fig. 5A , left), but clearly persisted in the spleen ( Fig.   3 5A, right), after expression of HDAC7ΔP was turned off. Blocking HDAC7 nuclear export in the thymus thus 4 apparently programs a more naïve-like state of differentiation into CD1D/αGalCer-reactive cells that persists 5 even after HDAC7-mediated repression is removed. 6 These data were also helpful in identifying key candidate molecular targets of HDAC7. IPA 7 analysis of putative upstream regulators of the HDAC7-affected gene set identified multiple targets highly 8 relevant to iNKT development and function, including PLZF, ID2, IL4, IFNG, T-bet, and GATA3 ( Fig. S4A,   9 for a complete list of putative upstream regulators see Table S3 ). The downstream targets of these were almost 10 universally affected in a manner that suggests inhibition rather than activation of the putative upstream 11 regulator. The expression of most of these upstream regulators was itself suppressed by HDAC7, suggesting 12 an obvious mechanism of regulation. However the Tec kinase ITK, the most highly correlated upstream 13 regulator of HDAC7 targets in both thymus and spleen, was only modestly suppressed in spleen and not 14 significantly suppressed in thymus, suggesting that HDAC7 might regulate its activation more than its 15 expression. ITK has a well-characterized role in the maturation of conventional CD8 T cells, CD8 innate 16 effectors, and iNKT cells (Atherly et al. 2006, Felices and Berg 2008) . 17 Similarly, PLZF expression was only modestly repressed by HDAC7ΔP ( Fig. 5A ), yet its downstream 18 targets were very highly correlated with the HDAC7 target gene set, based on both IPA analysis and 19 comparison of HDAC7-regulated genes with genes identified in a recent, comprehensive study of PLZF- Table S1 ), while one was positively correlated. Additionally, Mao, et al. identified 7 BACH2 as a crucial interaction partner of PLZF, and our own data show BACH2 as not differentially 8 expressed but nonetheless as one of the strongest putative upstream regulators of the HDAC7-regulated gene 9 set ( Fig. S4A ), suggesting that HDAC7 may modulate its targets via a ternary interaction with PLZF. This 10 remarkable degree of overlap strongly supports the idea that HDAC7 is a negative regulator of iNKT cell 11 development that functions at least in part by negatively regulating PLZF-dependent transcription. 12 Ontologic analysis of HDAC7-regulated genes using Ingenuity Pathway Analysis (IPA) provided 13 strong evidence for their association with both innate-like effector function and inflammatory disease. 14 Canonical pathways associated with the HDAC7-regulated gene set included multiple pathways associated 15 with innate immune signaling and T cell effector function ( Fig. S4B , green-shaded pathways, see Table S2 16 for a complete list of pathways and associated genes), as well as with inflammation and inflammatory disease 17 states ( Fig. S4A , blue-shaded pathways), particularly hepatic inflammation. This connection was brought into 18 even sharper relief by two recent GWAS studies of primary sclerosing cholangitis (PSC) and inflammatory 19 bowel disease (IBD), which both identified HDAC7 among the disease-associated loci, and also individually 20 its immediate upstream kinases PKD and SIK2, as well as two isoforms of PKC that are upstream of PKD 21 ( Fig. 6A ) (Liu et al. 2013 , Jostins et al. 2012 . Moreover, a remarkably high proportion of the other hits from 22 these studies are downstream of HDAC7, i.e. their expression in iNKT cells is altered by HDAC7ΔP. Of the 23 176 GWAS risk loci mapping to genes that were expressed in our RNA-seq data, 81 (46%) were regulated by 24 HDAC7 in NKT cells, a much higher degree of overlap than would be expected by chance (P = 3.49 X 10 -16 , 25 binomial distribution) ( Fig. 6A ). Of the 16 strongest risk loci identified by the Liu, et al. study of PSC, 10 were differentially expressed due to expression of HDAC7ΔP, and 4 more comprised HDAC7 itself, as well 1 as its upstream regulators PRKD2 and SIK2, and also PLZF interaction partner BACH2 (Parra et al To gain a better understanding of the significance of this overlap, we evaluated the 81 risk loci that 4 were regulated by HDAC7 with respect to regulation by PLZF, differential expression in iNKT cells vs. 5 Tconv, functional role in iNKT cell development, and functional role in autoimmune disease (Fig. 6B ). This 6 analysis revealed that a large proportion of these genes were functionally important in iNKT development 7 ( Fig. 6B , 6 th row), while relatively fewer were identified as PLZF targets (Fig. 6B , 3 rd row), suggesting that 8 HDAC7 affects autoimmunity and iNKT development via both PLZF-dependent and independent 9 mechanisms. We then further filtered the genes for significance in at least 4 of the 8 criteria examined (Fig   10   6B ), and then manually mapped the resulting 56 genes to their associated signaling pathways ( Fig. 6C ).
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Remarkably, all but 13 of these genes could be mapped to one of five interconnected signaling networks, 12 comprising Th1 and Th2 cytokine signaling, chemokine signaling, TCR signaling with its associated 13 costimulatory pathways, and signaling through cell membrane-associated TNF superfamily members ( Fig.   14   6C , dark-colored symbols with white label, gray-shaded areas). 15 These signaling networks are also heavily populated with HDAC7 targets that were not identified in 16 the GWAS studies ( Fig. 6C , light-colored symbols), an observation that is confirmed by IPA analysis of 17 canonical signaling pathways and upstream regulators among HDAC7 targets ( Fig. S5A-B ). In nearly all 18 cases, HDAC7 regulates these targets in a manner opposite to their regulation during iNKT cell development 19 ( Fig. 6C , symbol border vs. fill colors). This regulation by HDAC7 by clearly suppresses downstream 20 signaling in all cases except for TNF superfamily costimulatory signaling, which is potentiated ( Fig. 6C , color 21 of arrows per legend). Consistent with our phenotypic findings, nearly half of these genes have positive roles 22 in NK/NKT development/function (Fig. 6B) , showing that HDAC7 broadly suppresses several key signaling 23 pathways that are highly important in both NKT cells and in human autoimmune diseases that are similar to 24 the pathology observed in HDAC7ΔP transgenic mice. This remarkable concordance strongly supports the idea that the role of HDAC7 in these cells plays a role in the pathogenesis of PSC and IBD, and identifies a 1 few key signaling pathways as candidates for further interrogation. 2002). This suggested that HDAC7 might modulate PLZF activity in thymocytes through direct physical 12 binding. Determining if this is the case directly is somewhat challenging, however, as the abundance of PLZF 13 in wild-type thymocytes is very low, being restricted to a small population of iNKT precursors. To circumvent 14 this difficulty, we made cell lysates from PLZF-transgenic thymocytes and immunoprecipitated them with 15 antibodies to endogenous HDAC7. These experiments showed a specific interaction between HDAC7 and 16 PLZF in thymocytes ( Fig. 7A ). 17 To further define this interaction, we co-transfected FLAG-tagged full-length or truncated HDAC7 18 with full length HA-tagged PLZF (Fig. 7B, D) , or conversely different truncations of PLZF with the 19 (interacting) HDAC7 N-terminal adapter domain (residues 1-497, Fig. 7C , E). After Immunoprecipitation of 20 transfected lysates with anti-FLAG agarose beads, we quantified the amount of PLZF protein pulled down vs. 21 input levels over 3-6 separate experiments for each construct, using the LiCor Odyssey system ( Fig. 7D-E) . 22 The results of this analysis identify residues 65-200 of HDAC7, containing the MEF2-interacting domain 23 through the first PKD phosphorylation site, as the interacting region ( Fig. 7D ). Analysis of the PLZF deletions identified a region from residues 320-450, encompassing a proline-rich tract and the first two zinc finger 1 domains, as critical for interaction ( Fig. 7E ). Fig. 7F , medium blue bars). Measurement of luciferase activity in lysates from these 12 cells showed that co-transfection of FL HDAC7 with FL PLZF or the 1-460 truncation reduced transcription 13 from the Gal4-luc construct, while it did not affect transcription when co-transfected with the non-interacting 14 1-318 mutant (Fig. 7F ). Conversely, HDAC7-VP16 increased transcription from the interacting PLZF 15 constructs but not the non-interacting one (Fig. 7F) . These experiments, together with our characterization of 16 the HDAC7-PLZF interaction and transcriptional targets above, provide strong evidence that in thymocytes 17 HDAC7 regulates PLZF in the same manner as MEF2 and other transcription factors, functioning as a TCR 18 signal-dependent co-repressor that helps to silence PLZF-associated promoters in the absence of appropriate 19 signals. This mechanism is highly likely to account for at least part of the effect on HDAC7 on innate effector 20 differentiation. 21 Restoring iNKT Cells Ameliorates Tissue-Specific Autoimmunity 22 We earlier reported that HDAC7ΔP mice develop spontaneous tissue-specific autoimmunity, with 23 about 80% developing obliterative exocrine pancreatitis and concomitant T-cell infiltration in stomach, liver 24 and small intestine within eight months (Kasler et al. 2012). Although this had been previously attributed solely to a defect in negative selection of conventional thymocytes, the striking absence of iNKT cells in 1 HDAC7ΔP mice spurred us to consider whether disrupted innate effector development might also contribute 2 to this autoimmune syndrome. Indeed, the very tissues vulnerable to T-cell infiltration in HDAC7ΔP mice, 3 notably the small intestine, liver and hepatobiliary mucosa, are typically populated by PLZF-dependent innate 4 effectors such as iNKT and mucosal-associated invariant T (MAIT) cells (Fan and Rudensky 2016). We thus 5 set out to determine if restoring iNKT cells could alter the course of HDAC7ΔP-induced autoimmunity. 6 In our earlier studies, we found that that HDAC7ΔP-mediated autoimmunity is dominantly 7 transferable in mixed BM chimeras if a 5-fold excess of HDAC7ΔP-derived bone marrow is used. While 8 engraftment at these ratios produced comparable populations of WT and HDAC7ΔP Tconv in peripheral 9 tissues, we did not assess the reconstitution of the iNKT compartment in those studies (Kasler et al. 2012) , 10 leaving open the possibility that there was an uncharacterized recessive component to the autoimmunity.
Attempts to adoptively transfer mature iNKT cells directly into HDAC7ΔP mice failed to effectively restore 12 tissue-resident iNKT populations ( Fig. S6A-C) . Instead, we generated two sets of hematopoietic chimeras to 13 determine if restoring iNKT cells using Vα14 bone marrow could ameliorate disease compared to WT bone 14 marrow (Fig. 8A) . When irradiated recipients were reconstituted with a 1:5 mixture of Vα14: HDAC7ΔP bone 15 marrow, peripheral iNKT cells were effectively rescued to normal levels, while in recipients receiving a 1:5 16 WT: HDAC7ΔP mixture they were still essentially absent (Fig. 8B) . 17 Comparing these cohorts over time, we noted Vα14: HDAC7ΔP chimeras had significantly lower peak plasma 18 levels of ALT and AST, commonly used as an indication of liver damage, than WT: HDAC7ΔP chimeras 19 ( Fig. 8C ). Both cohorts eventually perished from exocrine pancreatitis and had similar pancreatic lipase levels 20 in plasma (Fig. S6D ), yet Vα14: HDAC7ΔP chimeras exhibited significantly improved body weight 21 maintenance in the first two months post-engraftment ( Fig. 8D, left) and a reduced overall mortality rate ( Fig.   22 8D, right) compared to WT: HDAC7ΔP chimeras. These results provide evidence that disruptions in innate 23 effector development, particularly the loss of iNKT cells in the hepatobiliary tract, exacerbates tissue specific autoimmunity in the HDAC7ΔP setting. Restoring this missing innate effector population resulted in enhanced 1 survival and a significant reduction in the severity of disease. effector subtypes that would not have been restored with Vα14 bone marrow, it is tempting to speculate that 20 restoring these other subsets might ameliorate tissue destruction and T-cell infiltration due to HDAC7ΔP in 21 other organs. 22 Innate effector T-cells are often considered frontline first-responders to infection that amplify and 23 orchestrate the early immune response to invading pathogens. Thus, it was somewhat surprising to uncover a 24 protective or anti-inflammatory role for iNKT cells in attenuating tissue destruction. Additional studies will be required to uncover the mechanisms through which iNKT cells provide protection, but for now we favor a 1 model in which innate effectors occupy tissue niches at their sites of residence, limiting access of other 2 immune cells into those sites. In HDAC7ΔP mice, escape of autoreactive Tconv due to impaired negative 3 selection may produce a potentially but not necessarily pathogenic population, which requires the additional 4 loss of PLZF-dependent innate effectors from their target tissues to create an opening for infiltration. This 5 "two-hit" model may explain multiple types of tissue-specific autoimmunity, in which genetic lesions that 6 generate excess self-reactive lymphocytes are coupled with separate or related defects in tissue-resident innate 7 effector populations at specific sites, rendering these tissues particularly vulnerable to attack. the genes that we identified as regulated by HDAC7 in iNKT development show a striking overlap with other 16 risk loci from these GWAS studies (Fig. 6A ), suggesting that the broad HDAC7 regulatory network may be 17 a crucial nexus that underlies susceptibility to several autoimmune diseases of considerable clinical 18 importance. Indeed, mapping the overlapping GWAS loci to their associated signaling networks revealed a 19 remarkable clustering around a few important signaling pathways in iNKT and effector development, 20 including IL12, IL21, IL18, IFNG, and IL4, as well as Ig-and TNF-superfamily costimulatory pathways. 21 Deciphering the complex relationship between HDAC7, PLZF and other HDAC7 interaction partners, the 22 observed modulation of these pathways, and the resulting cellular and pathologic phenotypes will be a major 23 task for us going forward. We hope that this effort will illuminate the way forward in translating our finding 24 that reestablishing missing iNKT cells can ameliorate HDAC7-mediated hepatic autoimmunity into potential 25 therapeutic modalities for the analogous human diseases, based on the restoration of innate effector function. For pulldown experiments, 10cm dishes seeded the previous day with 3.2X10 6 HEK 293T cells were 1 transfected with 20μg of total DNA, consisting of 10μg each of PLZF and HDAC7 constructs or the 2 corresponding empty vectors, using CaPO4/chloroquine. After 48 hours, cells were harvested for interaction 3 analysis. For reporter assays, 6-well dishes seeded with 0.8X10 6 HEK 293T cells/well were transfected using 4 CaPO4/chloroquine with 6.1μg of total DNA, consisting of 2 μg each of gal4(5) luc, gal4-PLZF fusion 5 construct, and empty vector or HDAC7 expression construct, plus 100ng of EF1α Renilla luciferase. Cells 6 were harvested for luciferase assay 48 hours after transfection, and luciferase activity was measured using the 7 Promega Dual-Luciferase assay kit. Co-immunoprecipitations and western blots. For the co-immunoprecipitation of endogenous HDAC7 with 10 transgenic PLZF in thymocytes, thymocyte lysates from wild-type and PLZF transgenic mice were prepared 11 using p300 lysis buffer (250 mM NaCl, 0.1% NP-40, 20 mM NaH2PO4, pH 7.5, 5 mM EDTA, 30 mM sodium 12 pyrophosphate, 10 mM NaF, and HALT protease/phosphatase inhibitors (Thermo Fisher Scientific). After 13 clarification (5 minutes, 13,000Xg) and pre-clearing (3 hours at 4°C with proteinA/G agarose beads), lysates 14 were immunoprecipitated with either 1µg/ml of α-HDAC7 antibody (H-273, Santa Cruz Biotechnology) or 15 1µg/ml of rabbit IgG isotype control antibody (Cell Signaling) at 4°C overnight. The lysates were then 16 incubated with 50µl of protein A/G agarose beads (Santa Cruz Biotechnology) at 4°C for 4 hours, followed 17 by washing 5 times with p300 lysis buffer. Immunoprecipitated proteins from the beads were eluted with non-18 reducing Laemmli SDS PAGE sample buffer by boiling for 3 min. For pulldown analysis of HDAC7-PLZF 19 truncation mutants, 10cm dished were harvested and lysed in 0.8mL of P300 buffer, clarified by spinning 5 20 min. at 13,000g, then incubated for 4 hours at 4°C with 30μL/sample of FLAG M2-agarose beads (Sigma). 21 After 4 washes with p300 buffer, bound proteins were eluted from the beads by addition of 100μL of reducing 22 Laemmli SDS-PAGE sample buffer, followed by a 5-minute incubation at 95°C. 23 After SDS PAGE and transfer to nitrocellulose, membranes were probed with antibodies against 24 HDAC7 (H-273, Santa Cruz Biotechnology), PLZF (D9, Santa Cruz Biotechnology), and β-actin (Abcam), 25 HA epitope (Cell Signaling), or FLAG epitope (Sigma), overnight at 4°C. After washing and incubation with 1 LiCor Odyssey scanner respectively. Bands for quantitative pulldown analysis were quantified from the 2 scanner output using ImageJ (Wayne Rasband, National Insititutes of Health). showing top putative upstream regulators of the sets of genes from Fig. 5A that were suppressed by HDAC7ΔP in thymus or spleen. Column 2 shows the average activation or inhibition z-score of the indicated genes, based on IPA analysis of differential regulation of their targets in the data. Column 3 shows the average log2 fold differential expression of the indicated genes in Vα14 X HDAC7ΔP vs Vα14 Tg thymocytes and splenocytes. (B) Table showing IPA top canonical signaling pathways overrepresented in the sets of genes from (A) that were suppressed by HDAC7ΔP in thymus or spleen. Red-shaded pathways refer to inflammation or inflammatory disease states, blue-shaded pathways to pathways involved in innate effector differentiation or function. (C) Heat maps showing differential expression values (red is upregulated, green downregulated) for the 11,470 genes sharing unique common IDs between our RNAseq data and data on the role of PLZF in iNKT cell development recently published in (Mao et al. 2016) . Columns 1-2
show the effect of HDAC7ΔP expression in PBS-57 tetramer-reactive Vα14 X HDAC7ΔP vs Vα14 Tg thymocytes (1) and splenocytes (2) from our RNA-seq data. Columns 3-4 show the differential expression of the same genes in Vα14
vs. naïve CD4SP Tconv in thymus (3) and spleen (4), also from our data. Columns 5-6 show differential expression of these genes in PLZF transgenic vs. wild-type CD4SP thymocytes (4), or in Vα14 X Luxoid (PLZF null) vs. Vα14 (5) PBS-57 tetramer-reactive CD4SP thymocytes, taken from published data (Cohen et al. 2013 , Mao et al. 2016 ), archived at GEO (accession GSE81772). The block at left shows differential expression values for 3,541 genes among the 11,470
common IDs that are >1.67-fold differentially expressed in at least one of the comparisons shown. The heat maps at center and right show 267 genes that are differentially expressed due to HDAC7ΔP expression (1, 2) and during NKT development (3, 4) , and also due to altered PLZF function (5, 6) . Identities are shown for 198 genes that are suppressed by HDAC7ΔP and enhanced by PLZF (center block), or conversely enhanced by HDAC7ΔP and suppressed by PLZF 
